Stock Price
0.37
Daily Change
-0.03 -7.50%
Monthly
8.82%
Yearly
273.74%
Q1 Forecast
0.37

Starpharma Holdings reported AUD876K in Cost of Sales for its fiscal semester ending in June of 2025.





Cost Of Sales Change Date
Medical Developments International AUD 2.18M 3.09M Jun/2025
Mesoblast USD 19.87M 34.61M Jun/2025
Neuren Pharmaceuticals AUD 7.45M 6.56M Jun/2025